Skip to main content

Posts

Showing posts with the label DRUG POLICY

Unveiling Methamphetamine: The Shadowy Depths of Addiction and Recovery

Unveiling Methamphetamine: The Shadowy Depths of Addiction and Recovery Unveiling Methamphetamine: The Shadowy Depths of Addiction and Recovery Methamphetamine , commonly known as crystal meth or simply meth, is a potent stimulant drug that has captured headlines for its devastating effects on individuals and communities worldwide. From its clandestine production in makeshift labs to its pervasive presence in urban and rural areas alike, methamphetamine represents a complex challenge that extends far beyond the realms of pharmacology. In this article, we delve into the intricate web of methamphetamine addiction, exploring its neurochemical effects, treatment strategies, and broader societal implications. Unveiling Methamphetamine: The Shadowy Depths of Addiction and Recovery The Rise of Methamphetamine: Methamphetamine's origins trace back to early 20th-century pharmaceutical development, where it was initially used to treat conditions like obesity and narcolepsy. However, its p

Don’t compound tragic effect of COVID-19 on HIV

Don’t compound tragic effect of COVID-19 on HIV The silent tragedy of the COVID-19 pandemic is its devastating impact on people with  other  health conditions. For those illnesses, declining attention has persisted even as the threat of COVID-19 is declining. HIV provides a striking example of the setback — and how the effects are looming in the shadows. In December, President  Biden  set a goal of  reducing new HIV infections  to just 3,000 a year by 2030, a decline of more than 90 percent from current levels. That goal is achievable as long as Congress and the administration are putting the right policies in place and people can access and afford their medications. Before the COVID-19 pandemic, efforts to  reduce HIV  in America was meeting some success — for a combination of reasons, including the mobilization of resources to get people tested and into care and the development of improved antiretrovirals for treatment and of PrEP for prevention. By 2019, annual deaths from AIDS had